The Catalyst

Archive

05.31.13 | By Jennifer Wall

The Catalyst is covering #ASCO13 this weekend and we’ll be posting ongoing thoughts on the pulse of the conference. We welcome your feedback and encourage you to leave comments below or tweet @PhRMA.   

05.31.13 | By Jennifer Wall

The Catalyst is covering #ASCO13 this weekend and we’ll be posting ongoing thoughts on the pulse of the conference. We welcome your feedback and encourage you to leave comments below or tweet @PhRMA.   

05.31.13 | By Kaelan Hollon

A troubling headline in the Wall Street Journal’s Africa section caught my attention earlier this week – “Africa’s Malaria Battle: Fake Drug Pipeline Undercuts Progress.” The article described customs officials in Angola finding a counterfeit Malaria drug disguised in a shipment of

05.31.13 | By Jennifer Wall

The Catalyst is covering #ASCO13 this weekend and we’ll be posting ongoing thoughts on the pulse of the conference. We welcome your feedback and encourage you to leave comments below or tweet @PhRMA.   

05.31.13

Over the course of the past 24 hours, thousands of physicians, researchers, advocates and executives have poured into Chicago for the annual meeting of the American Society of Clinical Oncology. The volume at the meeting is extraordinary: more than 20,000 attendees will swarm McCormick Place, thousands of others will fill nearby hotels.

05.30.13 | By Jenni Brewer

CMS wrote an informative Perspective article in the New England Journal of Medicine (NEJM) that highlights the important role of the physician community in the implementation of the Physician Payment Sunshine Act.  With over half of phy

05.30.13 | By Christian Clymer

As more U.S. cities become smoke free, we’re seeing first hand what the Centers for Disease Control and Prevention is saying – U.S. tobacco use has declined significantly. As a result, I was surprised to learn that worldwide tobacco consumption is actually growing.

05.28.13 | By Kaelan Hollon

Today marks the 15th Global Anti-Counterfeiting Day, and the following guest post was submitted by Marvin Shepherd, Bryan Liang and Thomas Kubic of the Partnership for Safe Medicines (PSM), a leading nonprofit organization fighting against counterfeit drugs.

05.28.13 | By Sascha Haverfield, Ph.D.

For more than 50 years, biopharmaceutical companies have partnered with the Food and Drug Administration (FDA) to help ensure the safety and efficacy of medicines.

05.24.13 | By Kaelan Hollon

If you’re like me, physical education class was a welcome break from history and math. Unfortunately, it is being cut from school programs.

05.24.13 | By Josie Martin

When President Nixon signed the National Cancer Act of 1971, there were three million cancer survivors. Today, there are more than 13 million. By 2022, this number will increase to 18 million.

05.23.13 | By Jennifer Wall

Bob Hugin, Chairman and CEO, Celgene and Chairman of the PhRMA Board, recently sat down with Life Science Leader magazine to talk about the value of medical innovation.  If you haven’t read it already, I urge you to do so because Bob offers some very insightful thoughts on why we

05.23.13 | By Jay Taylor

With TPP, Indian and other IP infringement and innovation issues shaping international headlines in recent weeks, IP is increasingly being recognized as a central driver of growth, development and access to medicines.

05.22.13 | By Jennifer Wall

Did you know that fewer than 40 percent of students who enter college intending to major in a STEM (science, technology, engineering and math) field actually graduate with a STEM degree?

This is very troubling.

05.22.13

PhRMA’s Rick Smith, Executive Vice President of Policy and Research, testified today in a hearing called, “10 Years Later: A Look at the Medicare Prescription Drug Program,” hosted by the Senate’s Special Committee on Aging.

05.22.13 | By Chip Davis

With the 17th round of Trans-Pacific Partnership negotiations taking place in Lima, Peru, the importance of strong U.S. trade and innovation policy is once again front and center.

05.22.13

In Colombia, unprecedented price controls in the private market are being contemplated and such policies – a threat to continued research and development of new medicines – are already in effect in El Salvador and also under consideration elsewhere in the region. 

05.21.13

This past weekend the American Journal of Managed Care released a study titled, “The Economic Impact of Medicare Part D on Congestive Heart Failure.”

05.20.13 | By Stephanie Fischer

Uplifting Athletes is a nonprofit organization that works with college football players to raise awareness of rare disease, raise funds for research and support individual rare disease patients.  The chapters are run by student athletes at universities across the country.  Their work recently gained national attention when the

05.17.13 | By Jennifer Wall

Recently, I had the pleasure of sitting down with Olof Larsson, chief scientific officer, Eli Lilly and Company, to talk about what inspired him to get into science and what advice he has for students as they explore their future career path.  I met Olof, originally from Sweden, at his house in Indianapolis, IN and as I walked through the front door, he introduced me to his daughter who is current

Pages